The 12th edition of the Pharma IPR Conference organized by Informa Markets will be held from 1-3 March 2023 in Mumbai. This is the only conference in India's pharmaceutical industry that focuses on Intellectual Property. The aim of this conference is to bring together all stakeholders in the pharma sector to discuss and deliberate on…
Weece Events is glad to invite you to attend the Global PHT Expo & Summit 2023 which is an International Conference & Exhibition on PHARMA, HEALTHCARE & TECHNOLOGY focusing on the Future of the Global Pharma & Healthcare Ecosystem in a digitally transforming world. The event is happening from 15-17th Feb 2023 at Hyatt Centric,…
Virtue Insight is glad to invite you to attend the 31st Pharmacovigilance 2023 which is happening on 01-02 February 2023 at Radisson RED London Heathrow, UK. The focus will be on the latest developments in pharmacovigilance, drug safety & risk management.
With the increasing number of diseases and the non-medical use of prescription drugs, the…
The trade fair CPHI & PMEC India started on 29th November 2022 to unlock new business opportunities. The event was for three days (29th, 30th Nov & 1st Dec) and organized by Informa Markets at the India Expo Centre, Greater Noida, Delhi NCR with Oceanic Pharmachem Pvt Ltd as a welcome partner, and Indian Pharma Post, Express Pharma,…
India is among the top 20 markets for medical devices worldwide. India's medical devices market stood at $11Bn in 2020 and is expected to reach $65Bn by 2024. The Government of India (GOI) has commenced various initiatives to strengthen the medical devices sector, with emphasis on R&D and 100% FDI for medical devices to boost…
The 6th Annual Medical Device Regulatory and Quality Summit conceptualized by Inventicon Business Intelligence on Oct 12-13th, 2022 in New Delhi, India in collaboration with Elmas Medical as gold partners and Starlims as silver partners, is one of the largest gatherings of medical devices professionals in the region.
The focus is to create a platform for…
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency
Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients
During the month of November, Bio-Thera Solutions reported the NMPA's acceptance of…
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency
Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients
During the month of October, Bio-Thera expanded its partnership with Pharmapark to…
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency
Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients
During the month of Jun, Celltrion launched Remsima SC (biosimilar, infliximab) for…
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency
Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients
During the month of Feb, Biocon collaborated with CHAI to expand access…

